LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

Search

Quanterix Corp

Închisă

SectorSănătate

4.71 -1.05

Rezumat

Modificarea prețului

24h

Curent

Minim

4.57

Maxim

4.82

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

16M

-16M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+57.56% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-56M

239M

Deschiderea anterioară

5.76

Închiderea anterioară

4.71

Sentimentul știrilor

By Acuity

15%

85%

11 / 351 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 mar. 2026, 19:08 UTC

Evenimente importante

TotalEnergies Shutting Production in Qatar, Iraq Amid Fighting in Middle East

13 mar. 2026, 18:48 UTC

Câștiguri
Principalele dinamici ale pieței

Capricor Therapeutics Falls on Wider-Than-Expected 4Q Loss

13 mar. 2026, 17:10 UTC

Evenimente importante

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

13 mar. 2026, 17:10 UTC

Evenimente importante

Week Ahead for FX, Bonds: Central Bank Decisions -2-

13 mar. 2026, 16:47 UTC

Evenimente importante

The Week in Oil: Hormuz Crisis Pushes Brent Above $100

13 mar. 2026, 22:27 UTC

Market Talk
Evenimente importante

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 mar. 2026, 22:13 UTC

Market Talk
Evenimente importante

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 mar. 2026, 22:04 UTC

Market Talk
Evenimente importante

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 mar. 2026, 22:00 UTC

Achiziții, Fuziuni, Preluări

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 mar. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

13 mar. 2026, 20:50 UTC

Market Talk
Evenimente importante

Financial Services Roundup: Market Talk

13 mar. 2026, 20:02 UTC

Market Talk

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 mar. 2026, 19:50 UTC

Market Talk
Evenimente importante

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 mar. 2026, 19:35 UTC

Evenimente importante

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

13 mar. 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

13 mar. 2026, 18:49 UTC

Evenimente importante

The Iran War Could Upend AI. Here's How. -- Barrons.com

13 mar. 2026, 18:24 UTC

Evenimente importante

Impact of Middle East Conflict on TotalEnergies Activities

13 mar. 2026, 18:00 UTC

Evenimente importante

Is War Good For the Economy? -- WSJ

13 mar. 2026, 17:23 UTC

Market Talk

U.S. Oil Rig Count Rises by 1 to 412 -- Market Talk

13 mar. 2026, 16:46 UTC

Market Talk
Evenimente importante

European Indexes End Week Lower as Oil Takes Driving Seat -- Market Talk

13 mar. 2026, 16:38 UTC

Evenimente importante

Higher Oil Prices Could Bring a Global Economic Shock. This Is the Number to Watch. -- Barrons.com

13 mar. 2026, 16:34 UTC

Achiziții, Fuziuni, Preluări

EQT Says It Received Around CHF21 Bln in Total From Galderma Share Sales

13 mar. 2026, 16:33 UTC

Achiziții, Fuziuni, Preluări

EQT Receives Proceeds of Around CHF1.3B From Sell-Down

13 mar. 2026, 16:32 UTC

Achiziții, Fuziuni, Preluări

EQT Completes Exit From Galderma

13 mar. 2026, 16:20 UTC

Market Talk
Evenimente importante

Financial Services Roundup: Market Talk

13 mar. 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

13 mar. 2026, 16:15 UTC

Evenimente importante

Why Exxon and Energy Stocks Finally Started to Rise This Week as the Iran War Escalated -- Barrons.com

13 mar. 2026, 16:11 UTC

Market Talk

Carney Tries to Put Dismal Canada Jobs Data in Context -- Market Talk

13 mar. 2026, 16:00 UTC

Evenimente importante

Here's Where the U.S. Economy Is Most Vulnerable to Iran War -- WSJ

13 mar. 2026, 15:48 UTC

Market Talk
Evenimente importante

Oil Futures Turn Higher as Supply Worries Remain -- Market Talk

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

57.56% sus

Prognoză pe 12 luni

Medie 7.5 USD  57.56%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

11 / 351 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat